PSMA-targeted imaging of prostate cancer: evolution of a success story

Por Maurer, Tobias, Eiber, Matthias
Publicado no Asian J Androl (2017)

A rare case of polyostotic fibrous dysplasia detected on (18)F-rhPSMA-7 PET/CT

Por Wang, Hui, Eiber, Matthias, Langbein, Thomas
Publicado no Eur J Nucl Med Mol Imaging (2020)

PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?

Por Maurer, Tobias, Murphy, Declan G., Hofman, Michael S., Eiber, Matthias
Publicado no Theranostics (2017)

[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery

Por Schottelius, Margret, Wirtz, Martina, Eiber, Matthias, Maurer, Tobias, Wester, Hans-Jürgen
Publicado no EJNMMI Res (2015)

Influence of sampling schedules on [(177)Lu]Lu-PSMA dosimetry

Por Rinscheid, Andreas, Kletting, Peter, Eiber, Matthias, Beer, Ambros J., Glatting, Gerhard
Publicado no EJNMMI Phys (2020)

Current Staging Procedures in Urinary Bladder Cancer

Por Maurer, Tobias, Horn, Thomas, Heck, Matthias, Gschwend, Jürgen E., Eiber, Matthias, Beer, Ambros J.
Publicado no Diagnostics (Basel) (2013)

(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

Por Rauscher, Isabel, Maurer, Tobias, Fendler, Wolfgang P., Sommer, Wieland H., Schwaiger, Markus, Eiber, Matthias
Publicado no Cancer Imaging (2016)

Double-strand breaks in lymphocyte DNA of humans exposed to [(18)F]fluorodeoxyglucose and the static magnetic field in PET/MRI

Por Brix, Gunnar, Günther, Elisabeth, Rössler, Ute, Endesfelder, David, Kamp, Alexandra, Beer, Ambros, Eiber, Matthias
Publicado no EJNMMI Res (2020)

The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model

Por Begum, Nusrat J., Glatting, Gerhard, Wester, Hans-Jürgen, Eiber, Matthias, Beer, Ambros J., Kletting, Peter
Publicado no Sci Rep (2019)

Multiparametric 18F–FDG PET/MR follow-up in a patient with autoimmune pancreatitis

Por Rauscher, Isabel, Eiber, Matthias, Algül, Hana, Siveke, Jens T., Weirich, Gregor, Schlitter, Anna M., Beer, Ambros J.
Publicado no Eur J Hybrid Imaging (2017)

Radiohybrid Ligands: A Novel Tracer Concept Exemplified by (18)F- or (68)Ga-Labeled rhPSMA Inhibitors

Por Wurzer, Alexander, Di Carlo, Daniel, Schmidt, Alexander, Beck, Roswitha, Eiber, Matthias, Schwaiger, Markus, Wester, Hans-Jürgen
Publicado no J Nucl Med (2020)

Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients

Por Bogdanovic, Borjana, Gafita, Andrei, Schachoff, Sylvia, Eiber, Matthias, Cabello, Jorge, Weber, Wolfgang A., Nekolla, Stephan G.
Publicado no Eur J Nucl Med Mol Imaging (2020)

Pre-test (68)Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model

Por Kraft, Pia, Maurer, Tobias, Gafita, Andrei, Krönke, Markus, Haller, Bernhard, Weber, Wolfgang A., Eiber, Matthias, Rauscher, Isabel
Publicado no EJNMMI Res (2020)

Synthesis and preclinical evaluation of novel (18)F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with (18)F-DCFPyl and (18)F-PSMA-1007

Por Robu, Stephanie, Schmidt, Alexander, Eiber, Matthias, Schottelius, Margret, Günther, Thomas, Hooshyar Yousefi, Behrooz, Schwaiger, Markus, Wester, Hans-Jürgen
Publicado no EJNMMI Res (2018)

Matched-Pair Comparison of (68)Ga-PSMA-11 PET/CT and (18)F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy

Por Rauscher, Isabel, Krönke, Markus, König, Michael, Gafita, Andrei, Maurer, Tobias, Horn, Thomas, Schiller, Kilian, Weber, Wolfgang, Eiber, Matthias
Publicado no J Nucl Med (2020)

Evaluation of SUV normalized by lean body mass (SUL) in (68)Ga-PSMA11 PET/CT: a bi-centric analysis

Por Gafita, Andrei, Calais, Jeremie, Franz, Charlott, Rauscher, Isabel, Wang, Hui, Roberstson, Andrew, Czernin, Johannes, Weber, Wolfgang A., Eiber, Matthias
Publicado no EJNMMI Res (2019)

Imaging prostate cancer with PSMA PET/CT and PET/MRI: current and future applications

Por Hope, Thomas A., Afshar-Oromieh, Ali, Eiber, Matthias, Emmett, Louise, Fendler, Wolfgang P., Lawhn-Heath, Courtney, Rowe, Steven P.
Publicado no AJR Am J Roentgenol (2018)

Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study

Por Dewes, Sabrina, Schiller, Kilian, Sauter, Katharina, Eiber, Matthias, Maurer, Tobias, Schwaiger, Markus, Gschwend, Jürgen E., Combs, Stephanie E., Habl, Gregor
Publicado no Radiat Oncol (2016)

11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer

Por Wieder, Hinrich, Beer, Ambros J., Holzapfel, Konstantin, Henninger, Martin, Maurer, Tobias, Schwarzenboeck, Sarah, Rummeny, Ernst J., Eiber, Matthias, Stollfuss, Jens
Publicado no Oncotarget (2017)

A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients

Por Peeken, Jan C., Shouman, Mohamed A., Kroenke, Markus, Rauscher, Isabel, Maurer, Tobias, Gschwend, Jürgen E., Eiber, Matthias, Combs, Stephanie E.
Publicado no Eur J Nucl Med Mol Imaging (2020)